Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia

Show full item record



Permalink

http://hdl.handle.net/10138/180169

Citation

Frismantas , V , Dobay , M P , Rinaldi , A , Tchinda , J , Dunn , S H , Kunz , J , Richter-Pechanska , P , Marovca , B , Pail , O , Jenni , S , Diaz-Flores , E , Chang , B H , Brown , T J , Collins , R H , Uhrig , S , Balasubramanian , G P , Bandapalli , O R , Higi , S , Eugster , S , Voegeli , P , Delorenzi , M , Cario , G , Loh , M L , Schrappe , M , Stanulla , M , Kulozik , A E , Muckenthaler , M U , Saha , V , Irving , J A , Meisel , R , Radimerski , T , Von Stackelberg , A , Eckert , C , Tyner , J W , Horvath , P , Bornhauser , B C & Bourquin , J-P 2017 , ' Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia ' , Blood , vol. 129 , no. 11 , pp. E26-E37 . https://doi.org/10.1182/blood-2016-09-738070

Title: Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia
Author: Frismantas, Viktoras; Dobay, Maria Pamela; Rinaldi, Anna; Tchinda, Joelle; Dunn, Samuel H.; Kunz, Joachim; Richter-Pechanska, Paulina; Marovca, Blerim; Pail, Orrin; Jenni, Silvia; Diaz-Flores, Ernesto; Chang, Bill H.; Brown, Timothy J.; Collins, Robert H.; Uhrig, Sebastian; Balasubramanian, Gnana P.; Bandapalli, Obul R.; Higi, Salome; Eugster, Sabrina; Voegeli, Pamela; Delorenzi, Mauro; Cario, Gunnar; Loh, Mignon L.; Schrappe, Martin; Stanulla, Martin; Kulozik, Andreas E.; Muckenthaler, Martina U.; Saha, Vaskar; Irving, Julie A.; Meisel, Roland; Radimerski, Thomas; Von Stackelberg, Arend; Eckert, Cornelia; Tyner, Jeffrey W.; Horvath, Peter; Bornhauser, Beat C.; Bourquin, Jean-Pierre
Other contributor: University of Helsinki, Institute for Molecular Medicine Finland
Date: 2017-03-16
Language: eng
Number of pages: 12
Belongs to series: Blood
ISSN: 0006-4971
DOI: https://doi.org/10.1182/blood-2016-09-738070
URI: http://hdl.handle.net/10138/180169
Abstract: Drug sensitivity and resistance testing on diagnostic leukemia samples should provide important functional information to guide actionable target and biomarker discovery. We provide proof of concept data by profiling 60 drugs on 68 acute lymphoblastic leukemia (ALL) samples mostly from resistant disease in cocultures of bone marrow stromal cells. Patient-derived xenografts retained the original pattern of mutations found in the matched patient material. Stromal coculture did not prevent leukemia cell cycle activity, but a specific sensitivity profile to cell cycle-related drugs identified samples with higher cell proliferation both in vitro and in vivo as leukemia xenografts. In patients with refractory relapses, individual patterns of marked drug resistance and exceptional responses to new agents of immediate clinical relevance were detected. The BCL2inhibitor venetoclax was highly active below 10 nM in B-cell precursor ALL (BCP-ALL) subsets, including MLL-AF4 and TCF3-HLF ALL, and in some T-cell ALLs (T-ALLs), predicting in vivo activity as a single agent and in combination with dexamethasone and vincristine. Unexpected sensitivity to dasatinib with half maximal inhibitory concentration values below 20 nM was detected in 2 independent T-ALL cohorts, which correlated with similar cytotoxic activity of the SRC inhibitor KX2-391 and inhibition of SRC phosphorylation. A patient with refractory T-ALL was treated with dasatinib on the basis of drug profiling information and achieved a 5-month remission. Thus, drug profiling captures disease-relevant features and unexpected sensitivity to relevant drugs, which warrants further exploration of this functional assay in the context of clinical trials to develop drug repurposing strategies for patients with urgent medical needs.
Subject: MINIMAL RESIDUAL DISEASE
1ST RELAPSE
CELL
XENOGRAFTS
CHILDREN
CANCER
DEPENDENCE
DASATINIB
PATIENT
MUTATIONS
3122 Cancers
3121 General medicine, internal medicine and other clinical medicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
Ex_vivo_drug_response_profiling.pdf 2.057Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record